retatrutide nonalcoholic steatohepatitis trial fatty liver disease nash A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis retatrutide nonalcoholic fatty liver disease
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3




























